Double gene-deleted strain of pseudorabies virus variant, construction method and application thereof
A pseudorabies virus, double-gene technology, applied to pseudorabies virus mutant double-gene deletion strains and its construction and application fields, can solve the problems of inability to provide immune protection, enhanced pathogenicity of PRV mutant strains, and antigenic variation , to achieve the effect of improving screening and purification efficiency and improving purification efficiency
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0032] The construction of embodiment 1 deletion virus
[0033] 1. Experimental method
[0034] 1.1 Construction of transfer vector
[0035] Two pairs of primers P1S / P1R and P2S / P2R were designed according to the US region gene sequence of PRV Kaplan strain (GenBank accession number JQ809328.1) and the deletion site of PRV Bartha-K61 strain (Table 1). Then take the PRV variant strain TJ strain virus DNA as a template, and use primers P1S / P1R (SEQ ID No.1 and SEQ ID No.2) and P2S / P2R (SEQ ID No.3 and SEQ ID No.4) to amplify respectively Left and right homologous recombination arms (L and R), and then L and R were cloned into the pOK12 vector through EcoRI and XbaI restriction sites to obtain the transfer vector pOK-LR. Using the pEGFP-N1 plasmid as a template, primers P3S / P3R (SEQ ID No.5 and SEQ ID No.6) (Table 1) were used to amplify the complete expression cassette containing EGFP and Neo genes. Then this fragment was cloned between the L and R fragments of pOK-LR through...
experiment example 1
[0046] Identification of experimental example 1 deletion virus strain rPRVTJ-delgE
[0047] 1. Experimental method
[0048] 1.1 Indirect immunofluorescence assay (Immunofluorescence assay, IFA)
[0049] Infect PK-15 cells with rPRVTJ-delgE-EGFP-Neo, rPRV-delgE strain and parental virus PRV TJ strain at 1MOI (multiplicity of infection, MOI)), and after 24h, the transitional virus rPRVTJ-delgE-EGFP-Neo inoculates the cells and places them directly Observed under a fluorescence microscope, the cells inoculated with rPRVTJ-delgE and the parental virus PRV TJ strain were fixed with cold absolute ethanol, and PRV gB (IDEXX, USA, batch number DJ358) and gE monoclonal antibody (IDEXX, USA, Batch number CJ291), after 2 hours at 37°C, wash the cells with PBS 5 times, add 1:80 diluted FITC-labeled goat anti-mouse IgG (Sigma Company), place in a wet box for 45 minutes at 37°C, wash 5 times with PBS , observed under an inverted fluorescence microscope.
[0050] 1.2 One-step growth curve...
experiment example 2
[0061] Experimental Example 2 Detection of the safety and immunogenicity of the deletion virus strain rPRVTJ-delgE in pigs
[0062] 1. Experimental method
[0063] 1.1 Immunity and attack
[0064] Twenty-one 35-day-old healthy piglets negative for both PRV antibody and antigen were selected and randomly divided into 5 groups. Among them, Group A and Group E each had 3 heads, and Groups B, C, and D each had 5 heads. Group A was inoculated with commercial pseudorabies Bartha-K61 strain attenuated vaccine (purchased from Harbin Veken Biotechnology Co., Ltd., production batch number 2012002), and the inoculation dose was 10 5 TCID 50 per head; groups B, C and D were inoculated with rPRVTJ-delgE strain, and the inoculation dose was 10 5 TCID 50 / head, 10 4 TCID 50 / head and 10 3 TCID 50 per head; Group E was inoculated with PBS at a dose of 1 mL / head. The inoculation site for all pigs was the left neck muscle. One week after immunization, all pigs were challenged with P...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com